WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.


Piperacillin-Tazobactam Breakpoints for Pseudomonas aeruginosa, 1st Edition

This CLSI rationale document is based on data compiled by the CLSI Working Group on Piperacillin-Tazobactam to reassess piperacillin-tazobactam breakpoints against Pseudomonas aeruginosa. 

This edition of the document was corrected in February 2024. Read the correction notices by accessing the link above, and learn more about our correction process here.

This document is available in electronic format only.

Member price:

List Price:
Log in/sign up to see price and add to cart


Chairholder: Romney M. Humphries, PhD, D(ABMM), FIDSA; Pranita D. Tamma, MD, MHS

Date of Publication: January 2, 2024

Order Code PDF: CLSI MR15Ed1E
ISBN Number: 978-1-68440-212-0

Order Code Print: print not available

Edition: First

Pages: 12